Active Government Funding Opportunities

This pilot award funds innovative ovarian cancer research that challenges current thinking and explores novel concepts to drive breakthrough discoveries. Projects must demonstrate exceptional scientific merit and innovative approaches to advance the field.

Mission Engineering Automation Testbed (MEAT) seeks prototypes for automated mission engineering and Live/Virtual/Constructive integration with secure interoperable ecosystem.

LYNX Software Technologies COTS software acquisition for Combat Rescue Helicopter development and sustainment operations.

Support high-impact investigator-initiated research addressing ovarian cancer through basic laboratory to translational studies. Projects must demonstrate strong scientific rationale with preliminary data and potential to advance patient care.

Support early-career ovarian cancer researchers through an intensive virtual academy offering mentoring, networking, and collaboration. The program develops productive scientists while advancing innovative ovarian cancer research in a structured peer-learning environment.

This DoD program funds breakthrough breast cancer research addressing major scientific challenges with potential for clinical impact. Researchers can pursue Level 1 or 2 funding, partnering with co-investigators and population science studies to accelerate discoveries from bench to bedside.

DoD funds breakthrough breast cancer research advancing toward clinical trials, requiring multidisciplinary teams with consumer advocates. This Level 4 award targets high-impact discoveries ready for human testing and clinical application.

Support early-career clinical trialists developing new ovarian cancer treatments through intensive mentoring, networking, and conducting translational research and early-phase clinical trials.

This award extends ongoing breast cancer clinical studies by completing data collection, follow-up, and analysis to maximize patient participation impact. It addresses knowledge gaps from early trial termination or incomplete data gathering.

This award funds clinical trials for new ovarian cancer treatments, from early proof-of-concept studies through large-scale efficacy trials. It supports evaluation of drugs, biologics, devices, and emerging technologies to improve patient outcomes.

Supports early-career breast cancer researchers demonstrating exceptional creative potential and innovative thinking. The award recognizes talented scientists with strong collaboration skills and leadership promise to advance meaningful solutions in breast cancer research.

DoD seeks breakthrough breast cancer research with high clinical potential, supporting projects from preclinical through early clinical stages. Applications must address priority research challenges and include consumer advocates as core team members.

Research and evaluate justice system responses to human trafficking and technology-enabled trafficking investigations, with focus on improving prosecutions, victim services, and law enforcement capabilities at the Southern Border.

Develop ALS therapeutics from preclinical validation through FDA IND-enabling studies. This award accelerates drug candidates toward clinical testing while requiring parallel development of mechanism-specific biomarkers for improved patient selection and trial design.

This DoD funding supports high-risk, hypothesis-driven research to discover new ALS drugs and therapies. Applications emphasizing novel approaches can succeed without preliminary data, enabling bold therapeutic innovation.

Develop and validate clinical biomarkers and outcome measures to improve ALS clinical trials, including digital health tools like wearables and AI-enabled monitoring. Projects should incorporate patient community input and may target specific ALS subtypes or therapeutic classes.

This DoD funding supports rapid clinical trials testing new ALS treatments, from phase 1 through small phase 2 studies. Focus areas include biomarker-driven interventions and improved clinical care approaches for managing the disease.

Support innovative, high-risk pancreatic cancer research ideas with potential for major breakthroughs. This award funds early-stage projects addressing key research priorities, including mentorship pathways for early-career investigators launching careers in pancreatic cancer science.

Develop uncertainty quantification for Lake Superior outflow rating equations using advanced CFD modeling and statistical water balance integration. This work improves discharge measurement accuracy for Great Lakes water management operations.

This award funds partnerships between clinicians and scientists to accelerate pancreatic cancer research from promising early-stage ideas toward clinical applications, including pilot trials and correlative studies.

This DoD program funds exploratory pancreatic cancer research with a patient-centered focus to develop innovative concepts and generate preliminary data for future clinical applications. Supported research should advance quality of life outcomes through robust studies that avoid preclinical animal work.

Support event planning and logistics for the 2027 MAST Plenary, a multilateral forum coordinating international efforts to safeguard sensitive technologies from WMD diversion and misuse through coordinated data collection and response strategies.

This DoD funding supports innovative research to transform Alzheimer's diagnosis and disease monitoring. Projects must demonstrate non-incremental solutions that overcome barriers to diagnosis and prognosis, with preliminary data and community collaboration required.

This DoD program funds clinical research and trials testing new care interventions for Alzheimer's disease and related dementia. Projects must demonstrate preliminary data, involve community collaboration, and address practical care solutions beyond drug testing.

Supports transformative research to identify and validate risk factors for Alzheimer's disease and develop prevention strategies. Projects must advance understanding of environmental, genetic, or lifestyle risks and propose actionable solutions to reduce AD/ADRD development.